CompanyDrug

Humanwell Healthcare’s Remimazolam Receives NMPA Approval for Bronchoscopy Use

CompanyDrug

Biosyngen’s First-in-Class Drug Candidate BRG01 Accepted for IND Review

Company

Zai Lab Reports Strong Revenue Growth in 2022 Interim Results

CompanyDrug

Alphamab Oncology’s KN019 Achieves Primary Endpoint in Phase II RA Study

CompanyDeals

WuXi Biologics Partners with neoX Biotech to Advance AI-Driven Drug Development

CompanyDeals

Luye Pharma’s Shandong Boan Partners with Shanghai Pharmaceutical for Biologics Manufacturing

CompanyDrug

Staidson’s STSP-0601 Receives Clinical Trial Approval for Hemophilia Treatment

CompanyDrug

Henlius Biotech Gets FDA Nod for HLX07 Clinical Study in CSCC

CompanyDeals

Suzhou Novoprotein Lists on Shanghai’s STAR Market for R&D Expansion

CompanyMedical Device

Rainmed Medical’s caFFR System Receives TGA Approval for Coronary Disease Diagnosis

CompanyDeals

NeuShen Therapeutics Closes $20M Series Pre-A Financing for CNS Drug Development

CompanyDrug

Zelgen Files NDA for Jacktinib to Treat Myelofibrosis in China